Japan vs Liberia: Treatment success rate for patients treated for MDR-TB
Japan
59.0%
in 2022
Liberia
59.0%
in 2022
Japan rank
125th
Liberia rank
125th
Treatment success rate for patients treated for MDR-TB over time
- Japan
- Liberia
How they compare
Japan currently reports 59.0% against 59.0% in Liberia, a difference of 0.0%.
Across all 7 years both countries report, Liberia has been ahead every year.
Japan ranks 125th and Liberia ranks 125th of 163 countries.
Liberia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 57.0% | 74.8% | 17.8% | Liberia |
| 2020s | 64.0% | 76.0% | 12.0% | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Japan or Liberia?
- Japan, at 59.0% against 59.0% in Liberia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Japan and Liberia?
- 0.0%, with Japan ahead.
- How many years of comparable data are there for Japan and Liberia?
- 7 years are reported by both, from 2016 to 2022.
- How do Japan and Liberia rank globally for treatment success rate for patients treated for mdr-tb?
- Japan ranks 125th and Liberia ranks 125th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.